Downloaded from https://www.everyspec.com 3–35. Personality, psychosexual conditions, transsexual, gender identity, exhibitionism, transvestism, voyeurism, other paraphilias, or factitious disorders; disorders of impulse control not elsewhere classified a.
A history of, or current manifestations of, personality disorders, disorders of impulse control not elsewhere classified, transvestism, voyeurism, other paraphilias, or factitious disorders, psychosexual conditions, transsexual, gender identity disorder to include major abnormalities or defects of the genitalia such as change of sex or a current attempt to change sex, hermaphroditism, pseudohermaphroditism, or pure gonadal dysgenesis or dysfunctional residuals from surgical correction of these conditions render an individual administratively unfit. b. These conditions render an individual administratively unfit rather than unfit because of physical illness or medical disability.
These conditions will be dealt with through administrative channels, including AR 135–175, AR 135–178, AR 635–200, or AR 600–8–24. 3–36. Adjustment disorders Situational maladjustments due to acute or chronic situational stress do not render an individual unfit because of physical disability, but may be the basis for administrative separation if recurrent and causing interference with military duty. 3–37. Eating disorders The causes for referral to an MEB are eating disorders that are unresponsive to treatment or that interfere with the satisfactory performance of duty. 3–38. Skin and cellular tissues The causes for referral to an MEB are as follows: a. Acne.
Severe, unresponsive to treatment, and interfering with the satisfactory performance of duty or wearing of the uniform or other military equipment. b. Atopic dermatitis . More than moderate, unresponsive to treatment, and which interferes with the Soldier’s performance of duty. c. Amyloidosis. Generalized. d. Cysts and tumors. (See paras 3–42 and 3–43.) e. Dermatitis herpetiformis. Not responsive to therapy. f. Dermatomyositis. g. Dermographism. Interfering with the performance of duty. h. Eczema, chronic. Regardless of type, when there is more than minimal involvement and the condition is unresponsive to treatment and interferes with the satisfactory performance of duty. i.
Elephantiasis or chronic lymphedema. Not responsive to treatment. j. Epidermolysis bullosa. k. Erythema multiforme. More than moderate and recurrent or chronic. l. Exfoliative dermatitis. Chronic. m. Fungal infections, superficial. If not responsive to therapy and interfering with the satisfactory performance of duty. n. Hidradenitis suppurative and/or folliculitis decalvans (dissecting cellulitis of the scalp). If unresponsive to treatment and interferes with the satisfactory performance of duty. o. Hyperhidrosis. On the hands or feet, when severe or complicated by a dermatitis or infection, either fungal or bacterial and not amenable to treatment. p.
Leukemia cutis or mycosis fungoides or cutaneous T–Cell lymphoma. (See also para 3–42.) q. Lichen planus. Generalized and not responsive to treatment. r. Lupus erythematosus. Cutaneous or mucous membranes involvement that is unresponsive to therapy and interferes with the satisfactory performance of duty. s. Neurofibromatosis. When interfering with the satisfactory performance of duty. t. Panniculitis. Relapsing, febrile, nodular. u. Parapsoriasis. Extensive and not controlled by treatment. v. Pemphigus. Not responsive to treatment and with moderate constitutional or systemic symptoms, or interfering with the satisfactory performance of duty. w. Psoriasis.
Extensive and not controllable by treatment. x. Radiodermatitis. If resulting in malignant degeneration at a site not amenable to treatment. y. Scars and keloids. So extensive or adherent that they seriously interfere with the function of an extremity or interfere with the performance of duty. z. Scleroderma. Generalized or of the linear type that seriously interferes with the function of an extremity. aa. Tuberculosis of the skin . (See paragraph 3–40.) 33 AR 40–501 • 14 December 2007